Project Grant 2338890

Award Date 6/1/24
Completion Date 5/31/29
Dollars Obligated $550K
Federal Grant Program
47.041
Assistance Type
Project Grant
Place of Performance
Birmingham, AL 35294, USA
Similar Awards
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Cooperative Agreement award of $1,000,000 to Theromics Inc., a minority-owned small disadvantaged business, aims to develop a novel protein-based gel to improve the effectiveness and safety of thermal tumor ablation procedures. The project will involve creating a computational model to predict the thermal behavior of the gel, conducting preclinical studies to quantify temperatures, ablation zone size,...
This STTR Phase I project, funded by the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084), aims to advance the development and evaluation of a hand-held induction heater device for treating pancreatic and prostate cancer using magnetic fluid hyperthermia (MFH) technology. The project, awarded to Ihnnova LLC, a small business located in Guánica, Puerto Rico, will receive $275,000 in funding over the period of October 1, 2024 to...
This federal Project Grant award of $374,095 from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), aims to develop a device that uses an infrared laser to enable local delivery of a high dose of chemotherapy to the surgical cavity after tumor resection. The technology employs thermosensitive liposomal nanoparticles encapsulating chemotherapy agents that...
This $275,000 Small Business Technology Transfer (STTR) Phase I grant from the National Science Foundation (CFDA 47.084 - NSF Technology, Innovation, and Partnerships program) was awarded to Oncoblaze LLC to develop a novel device for targeted delivery of chemotherapy agents to tissue surrounding surgically removed tumors. The project aims to address the issue of tumor recurrence after cancer surgery, which affects 30-40% of patients for certain cancers. The device uses an infrared laser to heat...
This $300,000 Project Grant awarded by the National Science Foundation (NSF) under the Integrative Activities (CFDA 47.083) program supports the development of an innovative, intelligent surgical probe for prostate cancer treatment. The project aims to create an edge artificial intelligence (AI) system-on-chip for bioimpedance analysis that can accurately distinguish cancerous from healthy tissue during prostate removal surgery. The novel technology being developed includes an adaptive filter to...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $275,000 to Cerflux Inc. aims to develop a personalized cancer treatment screening platform. The project will establish guidelines for handling solid tumor biopsy samples, generate 3D bioprinted tumor models for validation, and demonstrate the platform's ability to match patients with the most effective cancer treatments before treatment begins. This innovative approach has the...
This $274,594 Project Grant award from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) program supports research and development of an innovative technology for cancer diagnosis and treatment. The project aims to improve molecular profiling and clinical laboratory testing of cancer samples by optimizing microdissection techniques. The research will focus on modeling and optimizing the opto-thermal-mechanical interactions involved in microdissection to...
The National Science Foundation awarded a $255,731 Small Business Innovation Research Phase I Project Grant to Senoguard Inc. under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084). The grant funds the development and preclinical testing of a novel cryoablation probe system for post-lumpectomy margin ablation cancer treatment. Specifically, the company will design and optimize the probe for optimal contact and thermal transfer with tumor cells in fixed in vitro testing. The...
This Project Grant award of $305,000 from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) supports the development of a novel light-activatable nanoplatform for the targeted co-delivery of photodynamic therapy (PDT) and chemotherapy to treat peritoneal metastasis. The nanoplatform, developed by Glow Therapeutics Inc., a small minority-owned business, is designed to selectively target and eliminate cancer cells that remain after...
This federal Project Grant award of $545,682 from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), supports the development of a molecular toolbox for non-invasive methods to kill cells in situ via specific cell death pathways using safe, penetrant, and tunable temperature stimuli. The objective is to generate single protein constructs that can trigger...

CAREER: HEAT PENETRATION DEPTH AND DIRECTION CONTROL WITH CLOSED-LOOP DEVICE FOR PRECISION ABLATION -THIS PROJECT ADDRESSES A CRITICAL CHALLENGE IN CANCER TREATMENT: ENHANCING THE PRECISION OF THERMAL ABLATION TECHNOLOGY TO EFFECTIVELY TARGET TUMORS WHILE PRESERVING SURROUNDING HEALTHY TISSUES. BY 2030, IT IS ESTIMATED THAT OVER 26 MILLION NEW CANCER CASES WILL ARISE, WITH MORE THAN 10 MILLION POTENTIALLY TREATABLE THROUGH THERMAL ABLATION. CURRENT TECHNIQUES, HOWEVER, OFTEN COMPROMISE HEALTHY TISSUES DUE TO UNCONTROLLED HEAT SPREAD, OR THEY RISK TUMOR RECURRENCE BY FAILING TO ELIMINATE ALL CANCER CELLS. THIS PROJECT IS DEDICATED TO ADVANCING TUMOR PRECISION ABLATION (TPA), A TECHNIQUE DESIGNED TO PRECISELY CONTROL THE DISPERSION OF HEAT IN TISSUES ONCE IT IS SEPARATED FROM ITS SOURCE. THIS APPROACH IS ESPECIALLY CRUCIAL FOR ASYMMETRICALLY SHAPED TUMORS. THE PROJECT'S VISION IS TO ADVANCE SCIENCE AND TECHNOLOGY TO TRANSFORM CANCER TREATMENT BY DEVELOPING SAFER AND MORE EFFECTIVE ABLATION METHODS. THESE ADVANCEMENTS ARE PARTICULARLY VITAL FOR TREATING BRAIN TUMORS AND OTHER DISEASES WHERE TISSUE ABLATION IS A KEY THERAPEUTIC STRATEGY, INCLUDING LIVER, LUNG, KIDNEY, AND BONE TUMORS, EPILEPSY FOCI, MOTOR CIRCUITS IN MOVEMENT DISORDERS, AND VASCULAR ABNORMALITIES IN THE BRAIN. INTEGRAL TO THIS PROJECT IS AN EDUCATIONAL PLAN DESIGNED TO INVOLVE STUDENTS FROM UNDERREPRESENTED GROUPS IN STEM. THIS PLAN INCLUDES DEVELOPING INTERDISCIPLINARY COURSES THAT INTERSECT WITH MAJORS SUCH AS ELECTRICAL ENGINEERING, BIOMEDICAL ENGINEERING, AND ONCOLOGY. IT OFFERS RESEARCH OPPORTUNITIES FOR UNDERGRADUATE AND GRADUATE STUDENTS, PARTICULARLY THROUGH PROGRAMS LIKE VERTICALLY INTEGRATED PROJECTS. FURTHERMORE, IT PROVIDES MENTORSHIP OPPORTUNITIES FOR GRADUATE STUDENTS TO AID THEIR CAREER DEVELOPMENT. OUTREACH ACTIVITIES WILL BE ORGANIZED FOR SHARING RESOURCES, TOOLS, AND KNOWLEDGE WITH TEACHERS AND STUDENTS, AMPLIFYING THE PROJECT'S IMPACT. THIS PROJECT AIMS TO DEVELOP A NOVEL ABLATION CATHETER, A FIRST IN ITS FIELD, TACKLING SPECIFIC SCIENTIFIC CHALLENGES IN MODULATING HEAT PENETRATION AND DIRECTION DURING THERMAL ABLATION PROCEDURES. THE CORE SCIENTIFIC ADVANCEMENTS ENCOMPASS THREE MAIN AREAS: (1) LIMITING HEAT PENETRATION THROUGH A NEW METHOD THAT ALTERNATES HEATING AND COOLING TO CREATE A ZERO-TEMPERATURE GRADIENT AT THE TUMOR BOUNDARY, AIMING TO PREVENT DAMAGE TO ADJACENT HEALTHY TISSUES; (2) DIRECTING HEAT BY EXPLORING THE INTERACTION BETWEEN THE PHYSICS OF ULTRASOUND AND HEAT PROPAGATIONS, AND MODELING THIS INTERFERENCE, USING LOW-POWER ULTRASOUND WAVES TO PRECISELY DIRECT HEAT WITHIN TUMORS OF ASYMMETRICAL SHAPES; (3) REAL-TIME MONITORING EMPLOYING INNOVATIVE ULTRA-WIDEBAND (UWB) SENSORS FOR CONTINUOUS TRACKING OF THE ABLATION PROGRESS, THUS ENABLING ACCURATE AND IMMEDIATE CLOSED-LOOP CONTROL OF ABLATION PENETRATION DEPTH. THE PROPOSED RESEARCH PLAN COMPRISES THREE PHASES OF EVALUATION AND ASSESSMENT, INCLUDING IN VITRO TESTS AND IN VIVO EXPERIMENTS WITH TUMOR-BEARING SMALL ANIMALS. THE PROJECT'S INNOVATIVE APPROACH IN DEVELOPING THIS TPA CATHETER, INTEGRATING A HEAT PRODUCER-ABSORBER MODULE FOR APPLYING AN ALTERNATE HEATING AND FREEZING PROCESS, ULTRASOUND ARRAYS TO DIRECT THE HEAT IN THE DESIRED DIRECTION, AND UWB SENSORS FOR ABLATION DEPTH DETECTION, SIGNIFIES A LEAP FORWARD IN OUR UNDERSTANDING OF HEAT FLUX IN TISSUES. THIS INNOVATIVE APPROACH IS ANTICIPATED TO GREATLY INFLUENCE THE FIELDS OF MICROELECTRONICS, HEAT TRANSFER, AND TUMOR TREATMENT, OPENING NEW AVENUES IN PRECISION MEDICINE RESEARCH AND DEVELOPMENT. THIS AWARD REFLECTS NSF'S STATUTORY MISSION AND HAS BEEN DEEMED WORTHY OF SUPPORT THROUGH EVALUATION USING THE FOUNDATION'S INTELLECTUAL MERIT AND BROADER IMPACTS REVIEW CRITERIA.- SUBAWARDS ARE NOT PLANNED FOR THIS AWARD.

Posted 3/25/24, 12:00 AM